Introduction Semaglutide, A medication that has taken the healthcare world by storm, is revolutionizing the treatment landscape for individuals with type 2 diabetes and obesity. Initially developed as a treatment for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of drugs. By mimicking the natural hormone GLP-1, https://no1cancerscanninginindia61615.blazingblog.com/31636201/semaglutide-a-revolutionary-treatment-for-diabetes-obesity-and-cardiovascular-health